The traffi cking of falsifi ed and substandard medicinal products is a global socioeconomic problem, which poses a serious threat to economy and health of populations of most countries, including the Russian Federation.
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operation was given to uncontrolled Internet sale of medicinal products and biologically active additives at a price, which was signifi cantly higher than the actual costs, under the guise of highly effective means of treatment for various diseases. In General, in the Russian Federation 448 administrative offences were identifi ed, which resulted in withdrawal of more than 268 thousand units of medicines from illegal circulation, worth over 9 million rubles; 40 thousand falsifi ed and substandard preparations Contex and Durex for personal contraception were withdrawn. The mobile laboratory has conducted screening program of quality in respect of 294 samples of medicines. It identifi ed 20 parties of dubious authenticity. A message about 264 Internet sites which sell medicines in violation of applicable Russian legislation was sent to the coordinating headquarters of the General Secretariat of Interpol. An offi cial statement with Internet service providers on cessation of activities at these sites was issued [1] .
On 26-28 October 2011, Moscow hosted an international high-level conference on counterfeiting of medicinal products, which was attended by more than 750 professionals in the fi eld of law and pharmacy from different countries, including USA, China, countries of the European Council and the Commonwealth of Independent States. At the end of the conference the Convention on the counterfeiting of medicinal products and similar crimes involving threats to public health, was signed, which was called Medicrime [2] . Although there are some defi ciencies in the wording of these penal regulations, we believe their introduction in the Criminal Code is a serious step forward by the state to neutralize the traffi cking of falsifi ed and substandard medicinal products, and consequently to ensure the safety of the nation's health and economic security of the country. The inclusion of these special articles in the Criminal Code will allow to analyze statistical information on their practical application by the authorities, to investigate crimes, to fully implement the monitoring, prediction and prevention of these socially dangerous acts. It will contribute to the development and implementation of effective management decisions on the identifi cation and investigation of crimes of this type.
In recent years, in the framework of the joint preventive measures to combat the circulation of S39 falsifi ed and substandard medicinal products there has been some constructive interaction between law enforcement and regulatory authorities, primarily by the bodies of internal Affairs and units of the Federal Service on Surveillance in Healthcare of Russian Federation. During 2010-2013 researches in the fi eld of Economics, International and Criminal Law, Criminology, Criminalistics, Operatively-search activity, devoted to the development of measures to neutralize traffi cking of falsifi ed and substandard medicinal products, were developed as reserved dissertations. The legislation in the sphere of protection of public health and the turnover of medicines was updated. Thus, traffi cking of falsifi ed and substandard medicinal products in the Russian Federation at present is not an appeal and not a theory, but there is a real activity of specialists in the fi eld of law and pharmacy, with a certain legal framework, scientifi c and methodological support.
However, this problem is not yet solved. The Indicator of withdrawn from circulation of falsifi ed and substandard drugs remains high. In Russia by the end of 2014, 1 109 batches of substandard, falsifi ed and counterfeit medicines were detected and withdrawn from circulation. The volume of state quality control of medicines coming into circulation accounted for 16,3% [5] . A serious danger is the increased level of falsifi cation of pharmaceutical substances, 80% of which is imported to the Russian Federation on indirect contracts from China and India without proper control at customs posts.
The study of criminal cases and statistics about the traffi cking of falsifi ed and substandard medicinal products in the Russian Federation leads to the conclusion that this crime is of a latent character. Every year about 50 crimes are detected, for only 30-35 of them criminal cases are initiated, and only 15-20 of the investigated criminal cases are submitted to court. This indicates serious problems in proving the guilt of the perpetrators of these crimes and bringing them to justice. The fi ght against this crime requires long and reliable operational development of criminal groups, qualifi ed investigation and trial. The special knowledge in the fi eld of circulation of medicinal products is required at all stages, however, relevant educational programs to date have not been developed [6] . Traffi cking of dangerous medicines over the Internet and the media remains widespread in the Russian Federation. Biologically active additives are sold uncontrollably outside of pharmacies. The scale and danger of these crimes is erroneously determined on the basis of market value of the seized medicines, and not on the basis of their type of action and dosage, the presence of direct threat of harm to life and health due to the content of harmful substances. Obviously, a spread of just a few packages of falsifi ed or substandard medicines, which contain dangerous ingredients, or contain no active substances, can have irreversible impact for health of people.
CONCLUSIONS:
Detection, suppression, investigation and prevention of traffi cking of falsifi ed and substandard medicinal products should be systematic and not periodic in nature. It is necessary to organize training, close cooperation and continuous exchange of experience between specialists in the fi eld of criminal law and pharmacy in the fi ght against this criminal phenomenon.
Law enforcement and regulatory agencies need to adopt joint normative legal acts, regulating their functions and powers in joint fi ght against traffi cking of falsifi ed and substandard medicinal products.
The use of an offi cial position in the crimes related to traffi cking of counterfeit and substandard medicinal products should be considered as an aggravating circumstance when considering qualifi cation of those socially dangerous acts.
It is necessary to develop a set of measures to prosecute Internet service providers, hosting and serving web sites, through which they operate the illicit trade of medicinal products on the Internet.
We should develop a mechanism of accountability of media for advertising and distribution of obviously false information about medicinal products.
It is advisable to tighten control over the circulation of biologically active additives, prohibit their sale outside pharmacies.
